NCT05477329 is a NA clinical trial of Lenses in Myopia, sponsored by Shamir Optical Industry Ltd.

Who is sponsoring NCT05477329?

NCT05477329 is sponsored by Shamir Optical Industry Ltd.

What drugs are being tested in NCT05477329?

Interventions in NCT05477329: Lenses.

Is NCT05477329 still recruiting?

NCT05477329 is currently status unknown. Last updated 1 August 2022.

Last reviewed 2022-08-01 · How we verify

NCT05477329

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CHILDREN MYOPIA CONTROL

Status unknown NA Last updated 1 August 2022

What this trial tests

NA trial testing Lenses in Myopia in 136 participants. Status unknown.

Timeline

20 June 2021

Primary endpoint
30 June 2024

31 December 2024

Quick facts

Lead sponsor	Shamir Optical Industry Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	136
Start date	20 June 2021
Primary completion	30 June 2024
Estimated completion	31 December 2024
Sites	1 location across Israel

Drugs / interventions tested

Lenses

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

Shamir Optical Industry Ltd

Who can join

Adults 6 to 12, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this trial is evaluating the clinical effect of a myopia control spectacle lens compared to a single vision spectacle lens in slowing down the progression of myopia in children living in Israel.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Peripheral Defocus and Myopia Management: A Mini-Review.
Erdinest N, London N, Lavy I, Berkow D, et al · · 2023 · cited 44× · PMID 36796348 · DOI 10.3341/kjo.2022.0125

Verify or expand the search:

Other trials of Lenses

Trials testing the same drug.

NCT06161129 — Filter Lenses for the Prevention of Migraine Attacks · NA · not yet recruiting

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05477329 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shamir Optical Industry Ltd
Last refreshed: 1 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05477329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing